Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Sikdar et al., 2021)
Kim and colleagues designed a theranostic prodrug incorporating an HO-responsive boronated ester, which triggers the activation of a fluorescent coumarin moiety and the release of the potent anticancer agent SN-38 (Fig
TB 500 binds to G-actin, preventing its polymerization into F-actin (filamentous actin) and thereby maintaining a pool of free actin available for cellular motility and migration a process critical to wound healing and regeneration
Ongoing Guidance Regular check-ins and medical support help ensure your therapy is effective, safe, and aligned with your health goals
When we do, it will be within a supervised clinical framework
US$ 29.07
US$ 27.47
US$ 28.21
US$ 21.03
